Tumor Response in the Intention-to-Treat Population
’, extracranial lesions, intracranial lesions
DISEASE PROGRESSION
Abbreviations: NA, not applicable; OR, odds ratio.Responses were evaluated according to the Response Evaluation Criteria in Solid Tumours 1.1 guideline. Chemotherapy comprised pemetrexed, 500 mg/mAt disease progression, 50 patients had intracranial lesions progression only, 18 patients had extracranial lesions progression only, and 63 patients had simultaneous intracranial and extracranial lesions progression. Patients’ progressive patterns between the 2 groups is noted in eTable 1 in 